Eosinophilia
- 28 May 1998
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (22) , 1592-1600
- https://doi.org/10.1056/nejm199805283382206
Abstract
A marked accumulation of eosinophils occurs in several important disorders, such as allergic diseases, parasitic infections, and cancer.1 The level of eosinophils in the body is normally tightly regulated. In normal subjects, eosinophils account for only a small minority of peripheral-blood leukocytes, and their presence in tissues is primarily limited to the gastrointestinal mucosa.2 In certain disease states, however, eosinophils can selectively accumulate in the peripheral blood or any tissue in the body. Any perturbation that results in eosinophilia, defined here as an abnormal accumulation of eosinophils in blood or tissue, can have profound clinical effects. Eosinophilia may be harmful, . . .Keywords
This publication has 68 references indexed in Scilit:
- Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.The Journal of Experimental Medicine, 1995
- Molecular Mechanisms of Antiasthma TherapyAnnals of Medicine, 1995
- Phenotype of Cells Positive for lnterleukin-4 and lnterleukin-5 mRNA in Allergic Tissue ReactionsInternational Archives of Allergy and Immunology, 1995
- The effects of glucocorticoids on human eosinophilsJournal of Allergy and Clinical Immunology, 1994
- A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo.The Journal of Experimental Medicine, 1993
- Cyclosporin A in asthma therapy: a pharmacological rationaleJournal of Autoimmunity, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- The Immunobiology of EosinophilsNew England Journal of Medicine, 1991
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986